Back to search
FDAFDA · Food and drugs·Recall number D-1282-2015

Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100 count HDPE bottles, Rx only, Mutual Pharmaceutical, Philadelphia, PA, NDC 53489-217-01

Published August 5, 2015 · Recall initiated: July 9, 2015

Summary

FDA records drug Class II recall D-1282-2015, published August 5, 2015 and initiated July 9, 2015. Recalling firm: Mutual Pharmaceutical Company, Inc.; Status: Terminated; Reported quantity: 20,892 bottles; Lot: Lot #: 6676701 and 6676801, exp 1/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mutual Pharmaceutical Company, Inc.
Distributor
Nartionwide
Lot
Lot #: 6676701 and 6676801, exp 1/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100 count HDPE bottles, Rx only, Mutual Pharmaceutical, Philadelphia, PA, NDC 53489-217-01 recalled?

Yes. FDA published recall D-1282-2015 on August 5, 2015. Reported hazard: cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer

What should I do if I have this product?

Voluntary: Firm initiated · Letter